Based on this scientific background, the objective of the present research work was to measure in parallel circulating levels of sNRP1, Sema3E, and Slit2 by enzyme-linked immunosorbent assay (ELISA) in a larger case series of SSc patients, focusing on the peripheral vascular disease features. The gene discussed is SEMA3E; the disease is systemic sclerosis.